[go: up one dir, main page]

TR199903209T2 - Farmasötik bileşim. - Google Patents

Farmasötik bileşim.

Info

Publication number
TR199903209T2
TR199903209T2 TR1999/03209T TR9903209T TR199903209T2 TR 199903209 T2 TR199903209 T2 TR 199903209T2 TR 1999/03209 T TR1999/03209 T TR 1999/03209T TR 9903209 T TR9903209 T TR 9903209T TR 199903209 T2 TR199903209 T2 TR 199903209T2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
invention describes
words
composition
steroid
Prior art date
Application number
TR1999/03209T
Other languages
English (en)
Turkish (tr)
Inventor
Frank Parr Alan
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199903209T2 publication Critical patent/TR199903209T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
TR1999/03209T 1997-08-19 1998-08-17 Farmasötik bileşim. TR199903209T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717428.8A GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TR199903209T2 true TR199903209T2 (xx) 2000-05-22

Family

ID=10817619

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03209T TR199903209T2 (xx) 1997-08-19 1998-08-17 Farmasötik bileşim.

Country Status (15)

Country Link
EP (1) EP1007010A2 (xx)
JP (1) JP2002511101A (xx)
KR (1) KR20010014080A (xx)
CN (1) CN1263461A (xx)
AR (1) AR016629A1 (xx)
AU (1) AU9343098A (xx)
BR (1) BR9810458A (xx)
CA (1) CA2295016A1 (xx)
CO (1) CO4960657A1 (xx)
GB (1) GB9717428D0 (xx)
MA (1) MA26531A1 (xx)
PE (1) PE105699A1 (xx)
TR (1) TR199903209T2 (xx)
WO (1) WO1999008666A2 (xx)
ZA (1) ZA987392B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
CN102552917A (zh) 2003-08-13 2012-07-11 比奥孔有限公司 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂
WO2005066195A1 (de) * 2004-01-02 2005-07-21 Pharmacon Forschung Und Beratung Gmbh Verfahren zur herstellung von 1,2-ungesättigten azasteroiden
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
WO2010117873A2 (en) 2009-04-06 2010-10-14 Banner Pharmacaps, Inc. Progesterone solutions for increased bioavailability
ES2385240B1 (es) 2010-07-26 2013-09-23 Gp-Pharm, S.A. Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US8900631B2 (en) 2011-04-28 2014-12-02 Health Science Funding, LLC Dosage form to increase prasterone bioavailability
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
ES2555485T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
KR101679992B1 (ko) 2015-12-31 2016-11-28 주식회사 유유제약 프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
DE3607651A1 (de) * 1986-03-06 1987-09-10 Schering Ag Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
WO1999008666A3 (en) 1999-04-15
CN1263461A (zh) 2000-08-16
KR20010014080A (ko) 2001-02-26
CO4960657A1 (es) 2000-09-25
AR016629A1 (es) 2001-07-25
AU9343098A (en) 1999-03-08
WO1999008666A2 (en) 1999-02-25
GB9717428D0 (en) 1997-10-22
PE105699A1 (es) 1999-11-25
ZA987392B (en) 2000-02-17
EP1007010A2 (en) 2000-06-14
BR9810458A (pt) 2000-09-05
MA26531A1 (fr) 2004-12-20
CA2295016A1 (en) 1999-02-25
JP2002511101A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
ATE65023T1 (de) Pharmazeutische mittel.
TR200003666T2 (tr) Akut bir astım vakasının önlenmesi , tedavisi için formoterol
TR199903209T2 (xx) Farmasötik bileşim.
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
TR200000517T2 (tr) Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
TR200103039T2 (tr) Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon.
FI962799A0 (fi) Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
TR199800648A1 (xx) �ki veya daha fazla etken madde i�in ila� verme sistemi.
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
NO20005394L (no) Legemiddelavleveringssammensetninger bestående av klebende mikrosfærer
DK196189A (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
TR199903211T2 (xx) Azasteroitler içeren çözeltiler.
TR199901413T2 (xx) Eklem iltihab� i�in yeni tedavi.
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
MY101919A (en) Pharmaceutical compositions
BR0111678A (pt) Composições medicinais contendo derivados de propenona
TR199800526T2 (xx) Siklosporin i�erikli yumu�ak kaps�l terkipleri.
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
ES2126265T3 (es) Tableta de accion retardada con un cierto contenido de diclorofenaco de sodio.
AR002735A1 (es) Formulaciones liquidas de sustancias insecticidas activas.
RU97113599A (ru) Ранозаживляющая композиция "леста"
BE877982A (fr) Nouvelles 2-(5-pyrazolylamido)-2-imidazolines, utiles notamment comme agents anti-inflammatoires, et compositions pharmaceutiques les contenant